National Bank of Canada’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$570M Sell
620,178
-4,520
-0.7% -$4.58M 0.51% 41
2025
Q4
$671M Buy
624,698
+30,463
+5% +$29.1M 0.61% 30
2025
Q3
$453M Sell
594,235
-453,495
-43% -$337M 0.45% 41
2025
Q2
$817M Buy
1,047,730
+527,400
+101% +$410M 0.78% 24
2025
Q1
$430M Sell
520,330
-69,797
-12% -$58.1M 0.45% 42
2024
Q4
$456M Sell
590,127
-55,909
-9% -$46.3M 0.48% 44
2024
Q3
$572M Buy
646,036
+41,803
+7% +$37.6M 0.66% 28
2024
Q2
$552M Buy
604,233
+150,043
+33% +$120M 0.75% 24
2024
Q1
$345M Buy
454,190
+118,520
+35% +$84.3M 0.53% 37
2023
Q4
$199M Sell
335,670
-50,059
-13% -$29.2M 0.32% 67
2023
Q3
$207M Buy
385,729
+132,649
+52% +$68.4M 0.32% 77
2023
Q2
$117M Buy
253,080
+116,253
+85% +$48.8M 0.21% 100
2023
Q1
$47.3M Buy
136,827
+19,565
+17% +$6.6M 0.12% 151
2022
Q4
$42.9M Buy
117,262
+19,217
+20% +$6.81M 0.11% 166
2022
Q3
$31.5M Sell
98,045
-188,858
-66% -$59.8M 0.17% 126
2022
Q2
$93M Buy
286,903
+177,961
+163% +$53.4M 0.42% 55
2022
Q1
$31.3M Buy
108,942
+10,005
+10% +$2.57M 0.09% 206
2021
Q4
$27.3M Buy
+98,937
New +$25.1M 0.09% 187

Other funds holding LLY

National Bank of Canada's LLY Position: Q1 2026 in Review

National Bank of Canada reduced its Eli Lilly (LLY) stake by 0.72% in Q1 2026, selling an estimated $4.58M and leaving 620,178 shares worth $570M. The position accounts for 0.51% of the portfolio, ranked #41.

National Bank of Canada first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $817M in Q2 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • National Bank of Canada held 620,178 shares of Eli Lilly worth $570M as of Q1 2026.
  • National Bank of Canada sold 4,520 Eli Lilly shares in Q1 2026, an estimated $4.58M.
  • Eli Lilly made up 0.51% of National Bank of Canada's portfolio in Q1 2026, its #41 holding.
  • National Bank of Canada first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Eli Lilly position peaked at $817M in Q2 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.